#jn1-variant

#jn1-variant

The latest COVID-19 vaccine is about 54% effective at protecting people from symptoms of COVID-19, according to a report from the CDC.

The vaccine is 49% effective at protecting against symptoms from the JN.1 variant, despite being designed to target a different variant. [ more ]

The JN.1 variant is responsible for nearly all new COVID-19 cases in the United States, accounting for 93.1% of infections.

Key indicators are showing signs of decreasing COVID-19 activity nationally. [ more ]

The JN.1 variant of COVID-19 is currently the most widely circulating version of the virus in the US and globally.

The rapid evolution of the virus and low vaccination rates are contributing to the surge in cases of the JN.1 variant. [ more ]

Early data suggests the JN.1 variant of COVID-19 is not causing more severe disease.

The CDC is still waiting for more data to fully assess the impact of the JN.1 variant. [ more ]

The worst-hit counties for Covid-19 in Ireland last week were Mayo, Wexford, Kilkenny, Waterford, Westmeath, Laois, Donegal, Sligo, and Tipperary.

The more infectious JN1 Covid-19 variant is now the main strain circulating in Ireland, accounting for over 70% of recent samples analyzed.

A new study suggests that proteins involved in immune responses, blood clotting, and inflammation could be key factors in determining who is more vulnerable to long-Covid. [ more ]

The worst-hit counties for Covid-19 last week were Mayo, Wexford, Kilkenny, Waterford, Westmeath, Laois, Donegal, Sligo and Tipperary.

The JN1 Covid-19 variant is now the main strain circulating in Ireland, accounting for more than seven in 10 samples analyzed recently. [ more ]

A leading virologist warns that the new JN.1 variant could result in a bigger wave of COVID-19 cases than previous variants.

There may be a return to wearing face masks to prevent the spread of the JN.1 variant. [ more ]

The JN.1 variant of COVID-19 is rapidly spreading and represents a significant portion of cases, but vaccines and treatments are still effective against it.

Hospitalizations for COVID-19, influenza, and respiratory syncytial virus (RSV) are increasing, and levels of virus in wastewater are high, indicating the spread of infections. [ more ]

Bay Area and the country are experiencing high levels of COVID-19 cases and the new JN.1 variant is contributing to the surge.

Exposure to the virus for longer than one hour is a significant factor in transmission, according to a recent study. [ more ]

The JN.1 variant is rapidly rising to global dominance and is associated with the second-biggest wave of infections in the United States

The updated booster vaccine provides some protection against JN.1, but only 19% of eligible Americans have received it [ more ]